Cipla ascends value chain with $512m Medpro acquisition
This article was originally published in Scrip
Executive Summary
Cipla, has sealed a deal to acquire its partner firm and South Africa's third largest drug company, Cipla Medpro, for about $512 million as the Indian company makes a conscious shift away from its traditional risk-averse global partnerships-only approach to build an on-ground presence in key markets.